[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
""Shark Tank's Kevin Harrington Interviews $SGTM CEO Tony Raynor: Insights from the Original Shark" $CELG $BIIB $ANAB $EXAS $OSTK $ROKU $EIGR $FLXN $LJPC $PLXP $RARX $SYRS $IBB $XBI $VSTM $CRBP $GILD $AMGN $ABBV $LGND $ALNY $GERN $ALXN $PG $MRK $JNJ"
X Link @MoneyMaker0009 2025-10-16T13:51Z XXX followers, XX engagements
"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5601 followers, 8215 engagements
"For anyone who was long $CELG decades ago - remember $BMY effectively bailed these guys out from a mess of their own making. XX price hikes. Revlimid now costs $19660 the generic $17349 and it's only $XXXX to produce"
X Link @rekesk 2025-10-04T03:30Z XXX followers, XXX engagements
"Largest since $CELG for $JUNO acquisition i think. Next largest after $GMAB for $MRUS was maybe $GILD for $FTSV. Almost a handful of non oncology clinical stage acqusitions exceeding 8B since early 2018"
X Link @bio_clouseau 2025-09-29T15:55Z 20K followers, 3979 engagements